The Top 20 Pharmaceutical Companies -Based on 2010 revenues, in millions
There are no new names in Top 20 Pharma ranks, but mega-mergers and
patent expirations have re-shaped the upper end the list this year.
Pfizer stayed on top for another year (although it may choose to
abdicate), but Novartis creeped up from #3 to #2, boosted by its Alcon
revenues, and Merck jumped from #6 to #3 after integrating
Schering-Plough’s sales. Sanofi and GlaxoSmithKline, meanwhile, both
fell behind as their annual sales dropped from 2009. (Good thing Sanofi
will be able to add in some Genzyme revenues next year!)
Pharma is in the midst of some tumultuous times - foresee a lot more jockeying for position in the next several years.
—Gil Y. Roth Editor - Contract Pharma
| 1 | Pfizer |
$58,523
|
| 2 | ||
| 3 | ||
| 4 | ||
| 5 | ||
| 6 | ||
| 7 | ||
| 8 | ||
| 9 | ||
| 10 | ||
| 11 | ||
| 12 | ||
| 13 | ||
| 14 | ||
| 15 | ||
| 16 | ||
| 17 | ||
| 18 | ||
| 19 | ||
| 20 |
No comments:
Post a Comment